Literature DB >> 33025301

Changes in colorectal cancer incidence by site and age from 1973 to 2015: a SEER database analysis.

Lin Yang1, Shousheng Liu2, Zhenchong Xiong2, Huijiao Cao2, Wenzhuo He2, Qiankun Xie1, Chang Jiang2, Bei Zhang3, Liangping Xia4.   

Abstract

Previous studies have reported incidence and mortality declines for colorectal cancer (CRC). We evaluated recent temporal trends of colorectal cancer in the United States for the last 4 decades. Using the Surveillance, Epidemiology, and End Results (SEER) database, we identified primary CRCs diagnosed between 1973 and 2015. Temporal changes were evaluated by 6-year time periods. Age-adjusted incidence rates and annual percentage change (APC) for CRC were calculated by site and gender. Age-standardized relative survival rates were also evaluated. We identified 878,632 CRC patients, 51% of whom were men. For both genders, the proportions of new diagnoses of right-sided colon cancer (RCC) remained relatively stable, with the APC of - 0.8 and - 0.6 for the male and the female, respectively. There was a relative increase in RCC for the younger aged group (< 49 years). In contrast, the proportions of left-sided colon cancer (LCC) and rectosigmoid-cancer (RSC) decreased significantly over time. For those aged 0-49, the age adjusted incidence rates showed a small increase (in both genders), whereas age-adjusted incidence rates declined for those aged 50-64 and > 65 (in both genders). Our study showed near significance in the decline of CRC mortality rates in this population, except the 1-year age-standardized survival of LCC and RSC, and the 5-year age-standardized RCC in females. There was a significant increase in RCC for the younger aged group (< 49 years). In contrast, the proportions of LCC and RSC decreased significantly over time.

Entities:  

Keywords:  Age-standardized survival; Colorectal cancer; SEER database; Tumor location shift

Mesh:

Year:  2020        PMID: 33025301     DOI: 10.1007/s40520-020-01721-x

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  2 in total

Review 1.  Mucinous cystadenocarcinoma of the appendix. The controversy persists: a review.

Authors:  Nelson S F Lo; Michael G Sarr
Journal:  Hepatogastroenterology       Date:  2003 Mar-Apr
  2 in total
  2 in total

1.  Evaluation and Prediction Analysis of 3- and 5-Year Survival Rates of Patients with Cecal Adenocarcinoma Based on Period Analysis.

Authors:  Zi'an Shao; Shuai Zheng; Chong Chen; Jun Lyu
Journal:  Int J Gen Med       Date:  2021-10-28

2.  MicroRNA-490-3p inhibits migration and chemoresistance of colorectal cancer cells via targeting TNKS2.

Authors:  Jing Li; Rubing Mo; Linmei Zheng
Journal:  World J Surg Oncol       Date:  2021-04-13       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.